Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling
2013 · PLoS ONE · 114 citations
https://doi.org/10.1371/journal.pone.0064268
M
Martin Bak
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
156
Papers
4.3K
Citations
35
h-index
65
i10-index
Martin Bak is an academic researcher from Kangwon National University. The author has contributed to research in topics: Advanced Breast Cancer Therapies & Neuroscience and Neural Engineering & Breast Cancer Treatment Studies. The author has an h-index of 35, co-authored 133 publications.
ORCID: 0000-0002-6490-2519Papers by this author
worksVascular grading of angiogenesis: prognostic significance in breast cancer
2000 · British Journal of Cancer · 77 citations
https://doi.org/10.1054/bjoc.1999.0924
Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
2021 · Nature Communications · 77 citations
https://doi.org/10.1038/s41467-021-25422-9
Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer
2022 · npj Precision Oncology · 67 citations
https://doi.org/10.1038/s41698-022-00311-6
Long non-coding RNA expression profiles predict metastasis in lymph node-negative breast cancer independently of traditional prognostic markers
2015 · Breast Cancer Research · 58 citations
https://doi.org/10.1186/s13058-015-0557-4
Outcome of breast cancer screening in Denmark
2017 · BMC Cancer · 43 citations
https://doi.org/10.1186/s12885-017-3929-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat